Selected Start-Ups (04/01)
In Vivo summarizes the technology of several recently founded companies: BioWisdom Ltd. is an Internet R&D portal to support site users through all phases of drug discovery and development. Cardion AG will focus on heart disease treatment and cell transplantation using its platforms in gene therapy and stem cell technology. EngeneOS Inc. platform combines biological and engineered components to create programmable biomolecular machines. FemtoLink Biotechnologies LLC aims to accelerate its clients' discovery efforts with its integrated platform for molecular diagnostics of proteins, metabolites and DNA. Labnetics Inc. will develop low cost, disposable diagnostics using miniaturized sensor beads encased in silicon wafers. SyneCor LLC is an accelerator for new cardiovascular device companies.
You may also be interested in...
Developed by Japan’s national research institute, the supercomputer has been tasked with characterizing the SARS-CoV-2 virus, identifying therapeutic molecules, modeling infection spread and socio-economic impact.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Wound care company MiMedx has raised $150m in private equity and debt financing from EW Healthcare Partners and Hayfin Capital Management. The funds will be used to scale commercialization of the company’s amniotic tissue products.